THE VALUE OF METABOLITE IDENTIFICATION AND QUANTIFICATION IN CLINICAL STUDIES. SOME CASE STUDIES ENABLING EARLY ASSESSMENT OF SAFETY IN HUMANS: GLAXOSMITHKLINE